Kate Delaney

Kate Delaney is a seasoned professional in the field of regulatory patient engagement and outcomes research, currently serving as the Senior Director at BioMarin Pharmaceutical Inc. since May 2017. Delaney has held various leadership positions, including Senior Director of Global Patient Advocacy and Engagement, and Director of Regulatory Patient Engagement & Outcomes Research. Prior to BioMarin, Delaney was a partner at Shapiro & Delaney, providing expert consulting on neurocognitive testing and protocol development for children with lysosomal storage diseases and related conditions. Additionally, Delaney spent over 17 years at the University of Minnesota as a Senior Psychometrist and Research Program Manager, specializing in neurodegenerative conditions. Delaney's educational background includes degrees from the University of Iowa and the University of Minnesota.